Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents

J Chemother. 2012 Aug;24(4):240-2. doi: 10.1179/1973947812Y.0000000009.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Bordetella / classification
  • Bordetella / isolation & purification*
  • Bordetella Infections / complications
  • Bordetella Infections / immunology
  • Bordetella Infections / microbiology*
  • Bordetella Infections / therapy
  • Drug Therapy, Combination / adverse effects
  • Endocarditis, Bacterial / complications
  • Endocarditis, Bacterial / immunology
  • Endocarditis, Bacterial / microbiology*
  • Endocarditis, Bacterial / therapy
  • Hospitals, University
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Italy
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / microbiology
  • Male
  • Middle Aged
  • Prednisone / adverse effects
  • Prednisone / therapeutic use
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Azathioprine
  • Prednisone